Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Orexigen Therapeutics Inc. OREXQ

Healthcare Drug Manufacturers - Major
"Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity."

Recent & Breaking News (OTCPK:OREXQ)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Orexigen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- OREX

GlobeNewswire April 27, 2015

TRADING ALERT: The Rosen Law Firm Reminds Orexigen Therapeutics, Inc. Investors of the Important May 11, 2015 Deadline in the Class Action

Business Wire April 23, 2015

Orexigen Announces Receipt of Paragraph IV Certification Notice

PR Newswire April 22, 2015

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Orexigen Therapeutics, Inc. and a Lead Plaintiff Deadline of May 11, 2015

Business Wire April 21, 2015

Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Orexigen Therapeutics, Inc.

Business Wire April 20, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Orexigen Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 11, 2015 - OREX

PR Newswire April 15, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Orexigen Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire April 14, 2015

Law Offices of Howard G. Smith Reminds Investors of Orexigen Therapeutics, Inc. of the May 11, 2015 Deadline

Business Wire April 13, 2015

OREXIGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Orexigen Therapeutics, Inc.

Business Wire April 10, 2015

Orexigen Therapeutics to Speak at the Needham Healthcare Conference

PR Newswire April 10, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Orexigen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OREX

PR Newswire April 10, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Orexigen Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 11, 2015 -- OREX

GlobeNewswire April 10, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Orexigen Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- OREX

GlobeNewswire April 6, 2015

EQUITY ALERT: The Rosen Law Firm Reminds Orexigen Therapeutics, Inc. Investors of Important Deadline in Class Action - OREX

GlobeNewswire April 3, 2015

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Orexigen Therapeutics, Inc. Of Upcoming Deadline

Business Wire April 2, 2015

Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

PR Newswire March 30, 2015

OREXIGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orexigen Therapeutics, Inc. -- OREX

GlobeNewswire March 27, 2015

Barrack, Rodos & Bacine Has Filed an Investor Class Action Against Orexigen Therapeutics, Inc.

GlobeNewswire March 27, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Orexigen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- OREX

GlobeNewswire March 27, 2015

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Orexigen Therapeutics, Inc.

GlobeNewswire March 27, 2015